Home › Funds › Haven Capital Group, Inc. › IOVA

Haven Capital Group, Inc. position in IOVA

IOVANCE BIOTHERAPEUTICS INC · Health Care

Haven Capital Group, Inc. reported holding 59,143 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$876K, representing 0.67% of its reported portfolio and ranking #25 among its reported holdings. Haven Capital Group, Inc. has disclosed IOVA holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)59.14K sh
Reported value held$876.50K
Portfolio Weight0.67%
First reportedQ4 2024
Last changeNew
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Haven Capital Group, Inc.'s IOVA position evolved

Haven Capital Group, Inc. first disclosed a stake in IOVA in Q4 2024 at 124,449 shares (US$921K). Across 7 filings, Haven Capital Group, Inc. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 59,143 shares valued at US$876K. Notable position changes include a 29% trim in Q3 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 124.45K $920.92K New
Q1 2025 121.91K $406.00K Reduce
Q2 2025 106.51K $183.00K Reduce
Q3 2025 75.50K $164.00K Reduce
Q4 2025 59.14K $161.00K Reduce
Q1 2026 59.14K $207.59K Hold
Q3 2026 59.14K $876.50K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has Haven Capital Group, Inc. held IOVA?

Haven Capital Group, Inc. has disclosed IOVA holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

What is Haven Capital Group, Inc.'s current position in IOVA?

As of Q3 2026, Haven Capital Group, Inc. holds 59.14K shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $876.50K, representing 0.67% of its reported portfolio and ranking #25.

Has Haven Capital Group, Inc. been buying or selling IOVA?

In the latest 13F filing (Q3 2026), Haven Capital Group, Inc. newly opened its position in IOVA.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.